- Home
- BURL vs GMAB Comparison
BURL vs GMAB Comparison
Compare BURL & GMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BURL
- GMAB
- Stock Information
- Founded
- BURL 1972
- GMAB 1999
- Country
- BURL United States
- GMAB Denmark
- Employees
- BURL N/A
- GMAB N/A
- Industry
- BURL Department/Specialty Retail Stores
- GMAB Biotechnology: Pharmaceutical Preparations
- Sector
- BURL Consumer Discretionary
- GMAB Health Care
- Exchange
- BURL Nasdaq
- GMAB Nasdaq
- Market Cap
- BURL 16.1B
- GMAB 15.0B
- IPO Year
- BURL 2013
- GMAB N/A
- Fundamental
- Price
- BURL $290.32
- GMAB $20.80
- Analyst Decision
- BURL Strong Buy
- GMAB Buy
- Analyst Count
- BURL 16
- GMAB 8
- Target Price
- BURL $315.50
- GMAB $43.00
- AVG Volume (30 Days)
- BURL 700.4K
- GMAB 1.1M
- Earning Date
- BURL 03-06-2025
- GMAB 02-12-2025
- Dividend Yield
- BURL N/A
- GMAB N/A
- EPS Growth
- BURL 59.54
- GMAB 14.35
- EPS
- BURL 7.29
- GMAB 10.80
- Revenue
- BURL $10,475,057,000.00
- GMAB $2,967,926,227.00
- Revenue This Year
- BURL $11.65
- GMAB $32.03
- Revenue Next Year
- BURL $9.61
- GMAB $16.97
- P/E Ratio
- BURL $39.86
- GMAB $18.81
- Revenue Growth
- BURL 12.20
- GMAB 17.75
- 52 Week Low
- BURL $174.64
- GMAB $19.85
- 52 Week High
- BURL $298.89
- GMAB $31.88
- Technical
- Relative Strength Index (RSI)
- BURL 55.66
- GMAB 45.42
- Support Level
- BURL $283.96
- GMAB $19.89
- Resistance Level
- BURL $296.24
- GMAB $21.26
- Average True Range (ATR)
- BURL 7.49
- GMAB 0.40
- MACD
- BURL -0.26
- GMAB -0.02
- Stochastic Oscillator
- BURL 75.49
- GMAB 38.16
About BURL Burlington Stores Inc.
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
About GMAB Genmab A/S ADS
Genmab AS is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab to create Darzalex, which is regarded as the standard of care for multiple myeloma and is Genmab's leading product. Genmab also has Tepezza for thyroid eye disease (partnered with Horizon), Kesimpta for relapsing multiple sclerosis (partnered with Novartis), Rybrevant (partnered with Johnson & Johnson) for non-small cell lung cancer (NSCLC), Tivdak (partnered with Seagen) for cervical cancer, and Epkinly (partnered with AbbVie) for diffuse large B-cell lymphoma. Genmab has several pipeline candidates targeting other oncologic indications.